PY ..just a quick note .
Believe Lovaza sales in total are lower now then 5 yrs ago . There is reduced coverage for Omacor ( lovaza ) in Europe.
TG's jump around a lot depending on diet .
In the R-IT screening process they also screen you for how reliable a participant you will be . They emphasize the importance of the study and the safely of Vascepa and the placebo.
Most in the trial will be in their 60's , many with some college education ...so they ask, can you be a reliable, responsible participant here .
There is no down side to being in R-IT ...I would expect that over all , lipid panels could even improve in the placebo arm ...just more so in the active arm.
Re The Cardiologist who prescribed me Vascepa . I think the A Fib warning on Lovaza was a major concern for him for many of his patients . For me it was my stubbonly high LDL levels.
Kiwi
News 
Market Data 
Discover 
